Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Aligos Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +2 vs. Q1 2025
- Shares held
- 2.71M
- −589.4K (−17.9%) vs. Q1 2025
- Total value
- $19.5M
- −$7.57M (−27.9%) vs. Q1 2025
- New holders
- 9
- 9 more added
- Sold out
- 7
- 8 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ZRC Wealth Management, LLC | 4 | $29 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 10 | $72 | 0.00% | +10 | New |
| JPMorgan Chase & Co | 26 | $187 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 26 | $187 | 0.00% | +10+62.5% | Added |
| Advisor Group Holdings, Inc. | 220 | $1.59K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 500 | $3.60K | 0.00% | +500 | New |
| Tower Research Capital LLC (TRC) | 1,103 | $7.95K | 0.00% | −118−9.7% | Reduced |
| BNP Paribas Arbitrage, SA | 1,816 | $13.1K | 0.00% | +1,813+60,433.3% | Added |
| Royal Bank of Canada | 2,125 | $15.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,612 | $18.8K | 0.00% | −151,891−98.3% | Reduced |
| Golden State Wealth Management, LLC | 2,674 | $19.3K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,743 | $19.8K | 0.00% | −5,718−67.6% | Reduced |
| Acadian Asset Management LLC | 3,913 | $28.0K | 0.00% | +3,913 | New |
| Morgan Stanley | 4,005 | $28.9K | 0.00% | −3,493−46.6% | Reduced |
| Quest Partners LLC | 5,943 | $42.8K | 0.00% | −9,817−62.3% | Reduced |
| Goldman Sachs Group Inc | 10,231 | $73.8K | 0.00% | +10,231 | New |
| Two Sigma Investments, LP | 12,073 | $87.0K | 0.00% | +1,023+9.3% | Added |
| Millennium Management LLC | 12,315 | $88.8K | 0.00% | +12,315 | New |
| BlackRock, Inc. | 13,040 | $94.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 13,770 | $99.3K | 0.00% | −9,260−40.2% | Reduced |
| XTX Topco Ltd | 13,849 | $99.9K | 0.00% | +13,849 | New |
| Citadel Advisors LLC | 15,198 | $109.6K | 0.00% | +15,198 | New |
| Squarepoint Ops LLC | 18,589 | $134.0K | 0.00% | +18,589 | New |
| Charles Schwab Investment Management Inc | 25,398 | $183.1K | 0.00% | +12,712+100.2% | Added |
| LPL Financial LLC | 30,100 | $217.0K | 0.00% | +30,100 | New |
| Geode Capital Management, LLC | 34,048 | $245.5K | 0.00% | +5,978+21.3% | Added |
| Renaissance Technologies LLC | 52,544 | $378.8K | 0.00% | +12,968+32.8% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 76,247 | $549.7K | 0.02% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 83,055 | $598.8K | 0.01% | 00.0% | Unchanged |
| Readystate Asset Management LP | 136,782 | $986.2K | 0.04% | +91,382+201.3% | Added |
| Vanguard Group Inc | 139,776 | $1.01M | 0.00% | −973−0.7% | Reduced |
| Adage Capital Partners GP, L.L.C. | 140,000 | $1.01M | 0.00% | −325,000−69.9% | Reduced |
| Tang Capital Management LLC | 141,131 | $1.02M | 0.05% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 335,937 | $2.42M | 0.97% | +155,217+85.9% | Added |
| Alyeska Investment Group, L.P. | 412,000 | $2.97M | 0.01% | 00.0% | Unchanged |
| Deep Track Capital, LP | 444,110 | $3.20M | 0.10% | 00.0% | Unchanged |
| Woodline Partners LP | 518,300 | $3.74M | 0.02% | +202,917+64.3% | Added |
| Heights Capital Management, Inc | 0 | $0 | 0.00% | −241,500−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −241,500−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −88,569−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −40,612−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −38,254−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −11,216−100.0% | Sold out |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −10,199−100.0% | Sold out |